FR2230346A1 - Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposes - Google Patents
Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposesInfo
- Publication number
- FR2230346A1 FR2230346A1 FR7406237A FR7406237A FR2230346A1 FR 2230346 A1 FR2230346 A1 FR 2230346A1 FR 7406237 A FR7406237 A FR 7406237A FR 7406237 A FR7406237 A FR 7406237A FR 2230346 A1 FR2230346 A1 FR 2230346A1
- Authority
- FR
- France
- Prior art keywords
- ethyleneimine
- antigens
- immunogens
- production
- pharmaceutical purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 230000000415 inactivating effect Effects 0.000 title abstract 2
- 244000005700 microbiome Species 0.000 title abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 229960001212 bacterial vaccine Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 229960004854 viral vaccine Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32161—Methods of inactivation or attenuation
- C12N2770/32163—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2309329A DE2309329C2 (de) | 1973-02-24 | 1973-02-24 | Verwendung von Äthyleniminlösungen als Inaktivierungsmittel bei der Herstellung von Impfstoffen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2230346A1 true FR2230346A1 (en) | 1974-12-20 |
| FR2230346B1 FR2230346B1 (cs) | 1977-11-04 |
Family
ID=5873014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7406237A Granted FR2230346A1 (en) | 1973-02-24 | 1974-02-22 | Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposes |
Country Status (11)
| Country | Link |
|---|---|
| BR (1) | BR7401197D0 (cs) |
| CA (1) | CA1038757A (cs) |
| CS (1) | CS191909B2 (cs) |
| DE (1) | DE2309329C2 (cs) |
| DK (1) | DK132766C (cs) |
| ES (1) | ES423617A1 (cs) |
| FR (1) | FR2230346A1 (cs) |
| HU (1) | HU171544B (cs) |
| IN (1) | IN139338B (cs) |
| PL (1) | PL88703B1 (cs) |
| RO (1) | RO64304A (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU78955A1 (de) * | 1978-01-27 | 1979-09-06 | Chimicasa Gmbh | Verfahren zur inaktivierung von viren |
-
1973
- 1973-02-24 DE DE2309329A patent/DE2309329C2/de not_active Expired
-
1974
- 1974-02-19 RO RO7400077745A patent/RO64304A/ro unknown
- 1974-02-19 BR BR1197/74A patent/BR7401197D0/pt unknown
- 1974-02-21 CS CS741291A patent/CS191909B2/cs unknown
- 1974-02-22 CA CA193,307A patent/CA1038757A/en not_active Expired
- 1974-02-22 DK DK97974*#A patent/DK132766C/da not_active IP Right Cessation
- 1974-02-22 FR FR7406237A patent/FR2230346A1/fr active Granted
- 1974-02-22 HU HU74BA00003034A patent/HU171544B/hu unknown
- 1974-02-23 PL PL1974169031A patent/PL88703B1/pl unknown
- 1974-02-25 ES ES423617A patent/ES423617A1/es not_active Expired
- 1974-02-26 IN IN401/CAL/74A patent/IN139338B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2309329C2 (de) | 1983-05-11 |
| CA1038757A (en) | 1978-09-19 |
| DE2309329A1 (de) | 1974-08-29 |
| FR2230346B1 (cs) | 1977-11-04 |
| HU171544B (hu) | 1978-02-28 |
| DK132766B (da) | 1976-02-02 |
| PL88703B1 (cs) | 1976-09-30 |
| ES423617A1 (es) | 1976-11-01 |
| DK132766C (da) | 1976-07-05 |
| RO64304A (fr) | 1978-08-15 |
| BR7401197D0 (pt) | 1974-11-05 |
| CS191909B2 (en) | 1979-07-31 |
| IN139338B (cs) | 1976-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950701822A (ko) | 간염B 표면 항원 및 다른 항원으로 구성된 조합 백신(Combined vaccines comprising hepatitis B surface antigen and other antines) | |
| SE9102976D0 (sv) | Hybrid dna vektorer, encelliga organismer och bakterier till anvaendning foer produktion av hiv-proteiner och peptider | |
| BR8807376A (pt) | Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado | |
| GB1059676A (en) | Process for stabilising biologically active proteinaceous materials | |
| FR2230346A1 (en) | Inactivating microorganisms with ethyleneimine - in the production of antigens or immunogens for pharmaceutical purposes | |
| ES421549A1 (es) | Un procedimiento para preparar una vacuna de virus vivos para las vias respiratorias de ganado bovino. | |
| ES440256A1 (es) | Procedimiento y aparato de fabricacion de productos destina-dos a su utilizacion en forma de aerosoles. | |
| ES379642A1 (es) | Procedimiento para la obtencion de vacunas perfeccionadas. | |
| ES8107024A1 (es) | Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina. | |
| FR2270891A2 (en) | Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria | |
| DK0636030T3 (da) | Pasteurella haemolytica type A-1-bacterin-toxoid-vaccine | |
| IL67818A0 (en) | Vaccines comprising ozone inactivated organisms and their production | |
| Dougan et al. | Live bacterial vaccine for delivering antigens to the mammalian immune system. | |
| SU586579A1 (ru) | Способ получени холерного анатоксина | |
| SU511743A1 (ru) | Способ получени ассоциированной вакцины | |
| SU123670A1 (ru) | Вакцина против ботулизма норок и способ ее изготовлени | |
| GB1436323A (en) | Cell and virus culture systems | |
| FR2150799A1 (en) | Equine infectious anaemia - prepn of immunising vaccine | |
| FR2047886A1 (en) | Non-toxic anti-whooping cough vaccine | |
| FR1604144A (en) | Cerebrospinal meningitis vaccine | |
| GB770852A (en) | Vaccine products and process of producing the same | |
| NL7408579A (en) | Vaccine against respiratory infections esp in horses - contg an adsorbed, killed suspension of reovirus in water | |
| ES301910A1 (es) | Procedimiento para la preparacion de una vacuna contra la tuberculosis. | |
| ES458038A1 (es) | Procedimiento para la preparacion de agentes inmunogenos contra la peste porcina. | |
| DK49685A (da) | Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |